Q2 EPS Estimate for Phibro Animal Health Raised by Analyst

Phibro Animal Health Co. (NASDAQ:PAHC) – Research analysts at Zacks Research raised their Q2 2026 EPS estimates for Phibro Animal Health in a research note issued on Tuesday, January 7th. Zacks Research analyst R. Department now anticipates that the company will post earnings per share of $0.49 for the quarter, up from their previous estimate of $0.47. The consensus estimate for Phibro Animal Health’s current full-year earnings is $1.62 per share. Zacks Research also issued estimates for Phibro Animal Health’s Q3 2026 earnings at $0.36 EPS, Q4 2026 earnings at $0.50 EPS, FY2026 earnings at $1.66 EPS and FY2027 earnings at $2.12 EPS.

A number of other research analysts have also issued reports on PAHC. Barclays boosted their price target on Phibro Animal Health from $13.00 to $20.00 and gave the stock an “underweight” rating in a research report on Tuesday, November 12th. StockNews.com raised shares of Phibro Animal Health from a “buy” rating to a “strong-buy” rating in a report on Saturday, January 4th. Finally, Morgan Stanley raised their target price on shares of Phibro Animal Health from $20.00 to $25.00 and gave the company an “equal weight” rating in a research note on Tuesday, December 17th. Two research analysts have rated the stock with a sell rating, two have issued a hold rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, Phibro Animal Health has an average rating of “Hold” and an average target price of $20.50.

Phibro Animal Health Stock Performance

Shares of NASDAQ PAHC opened at $21.48 on Thursday. Phibro Animal Health has a 12-month low of $10.03 and a 12-month high of $25.98. The company has a market cap of $870.00 million, a PE ratio of 49.95, a P/E/G ratio of 0.58 and a beta of 0.53. The stock has a 50 day simple moving average of $22.81 and a 200-day simple moving average of $21.06. The company has a current ratio of 3.23, a quick ratio of 1.69 and a debt-to-equity ratio of 1.81.

Institutional Investors Weigh In On Phibro Animal Health

A number of institutional investors and hedge funds have recently bought and sold shares of PAHC. Brandes Investment Partners LP raised its holdings in shares of Phibro Animal Health by 1.2% in the 2nd quarter. Brandes Investment Partners LP now owns 2,405,629 shares of the company’s stock worth $40,521,000 after purchasing an additional 29,071 shares in the last quarter. Dimensional Fund Advisors LP lifted its position in shares of Phibro Animal Health by 5.7% during the 2nd quarter. Dimensional Fund Advisors LP now owns 775,470 shares of the company’s stock valued at $13,005,000 after acquiring an additional 42,086 shares during the last quarter. Dana Investment Advisors Inc. boosted its stake in shares of Phibro Animal Health by 17.2% during the 2nd quarter. Dana Investment Advisors Inc. now owns 513,926 shares of the company’s stock worth $8,619,000 after acquiring an additional 75,546 shares in the last quarter. Geode Capital Management LLC grew its holdings in shares of Phibro Animal Health by 5.7% in the 3rd quarter. Geode Capital Management LLC now owns 507,469 shares of the company’s stock worth $11,430,000 after acquiring an additional 27,201 shares during the last quarter. Finally, American Century Companies Inc. raised its position in shares of Phibro Animal Health by 119.6% during the second quarter. American Century Companies Inc. now owns 347,191 shares of the company’s stock worth $5,822,000 after purchasing an additional 189,068 shares during the period. 99.34% of the stock is owned by institutional investors and hedge funds.

Phibro Animal Health Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Wednesday, December 18th. Investors of record on Wednesday, November 27th were paid a dividend of $0.12 per share. The ex-dividend date of this dividend was Wednesday, November 27th. This represents a $0.48 annualized dividend and a yield of 2.23%. Phibro Animal Health’s dividend payout ratio is currently 111.63%.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.